Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 738020, 11 pages
http://dx.doi.org/10.1155/2015/738020
Research Article

EPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome between Variola Virus and Related Pathogenic Orthopoxviruses

1School of Medicine, Unit of Immunology, Complutense University of Madrid, Pza. Ramón y Cajal, s/n, 28040 Madrid, Spain
2School of Life and Health Sciences, University of Aston, Aston Triangle, Birmingham B4 7ET, UK

Received 26 June 2015; Revised 8 September 2015; Accepted 1 October 2015

Academic Editor: Jacek Tabarkiewicz

Copyright © 2015 Magdalena Molero-Abraham et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Hopkins, The Greatest Killer: Smallpox in History, with a New Introduction, University of Chicago Press, Chicago, Ill, USA, 2002.
  2. F. Fenner, R. Wittek, and K. Dumbell, The Orthopoxviruses, Academic Press, San Diego, Calif, USA, 1998.
  3. R. M. L. Buller and G. J. Palumbo, “Poxvirus pathogenesis,” Microbiological Reviews, vol. 55, no. 1, pp. 80–122, 1991. View at Google Scholar · View at Scopus
  4. D. Baxby, “Poxvirus hosts and reservoirs. Brief review,” Archives of Virology, vol. 55, no. 3, pp. 169–179, 1977. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Moss, “Poxviridae. The virus and their replication,” in Fields Virology, B. N. Fields, D. M. Knipe, and P. M. Howley, Eds., pp. 2849–2883, Lippincott-Raven Publishers, Hagerstown, Md, USA, 2001. View at Google Scholar
  6. K. L. Roberts and G. L. Smith, “Vaccinia virus morphogenesis and dissemination,” Trends in Microbiology, vol. 16, no. 10, pp. 472–479, 2008. View at Publisher · View at Google Scholar
  7. I. V. Babkin and I. N. Babkina, “The origin of the variola virus,” Viruses, vol. 7, no. 3, pp. 1100–1112, 2015. View at Publisher · View at Google Scholar
  8. S. N. Shchelkunov, S. S. Marennikova, and R. W. Moyer, Orthopoxviruses Pathogenic for Humans, Springer, Berlin, Germany, 2005.
  9. S. Parker, A. Nuara, R. M. L. Buller, and D. A. Schultz, “Human monkeypox: an emerging zoonotic disease,” Future Microbiology, vol. 2, no. 1, pp. 17–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. McFadden, “Poxvirus tropism,” Nature Reviews Microbiology, vol. 3, no. 3, pp. 201–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Henderson and B. Moss, “Smallpox and vaccinia,” in Vaccines, S. A. Plotkin and W. A. Orenstein, Eds., W.B. Saunders Company, Philadelphia, Pa, USA, 1999. View at Google Scholar
  12. L. Sánchez-Sampedro, B. Perdiguero, E. Mejías-Pérez, J. García-Arriaza, M. Di Pilato, and M. Esteban, “The evolution of poxvirus vaccines,” Viruses, vol. 7, no. 4, pp. 1726–1803, 2015. View at Publisher · View at Google Scholar
  13. E. R. Tulman, G. Delhon, C. L. Afonso et al., “Genome of horsepox virus,” Journal of Virology, vol. 80, no. 18, pp. 9244–9258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. L. Jacobs, J. O. Langland, K. V. Kibler et al., “Vaccinia virus vaccines: past, present and future,” Antiviral Research, vol. 84, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Jenner, An Inquiry into the Causes and Effects of the Variolae Vaccinae: A Disease Discovered in Some of the Western Counties of England, Particularly Gloucestershire, and Known by the Name of the Cow Pox, Sampson Low, London, UK, 1798.
  16. H. Nishiura and M. Eichner, “Estimation of the duration of vaccine-induced residual protection against severe and fatal smallpox based on secondary vaccination failure,” Infection, vol. 34, no. 5, pp. 241–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Henderson, T. V. Inglesby, J. G. Bartlett et al., “Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense,” The Journal of the American Medical Association, vol. 281, no. 22, pp. 2127–2137, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Fenn, “Biological warfare in eighteenth-century North America: beyond Jeffery Amherst,” Journal of American History, vol. 86, no. 4, pp. 1552–1580, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Maurer, B. Harrington, and J. M. Lane, “Smallpox vaccine: contraindications, administration, and adverse reactions,” American Family Physician, vol. 68, no. 5, pp. 889–896, 2003. View at Google Scholar · View at Scopus
  20. R. B. Kennedy, I. G. Ovsyannikova, R. M. Jacobson, and G. A. Poland, “The immunology of smallpox vaccines,” Current Opinion in Immunology, vol. 21, no. 3, pp. 314–320, 2009. View at Publisher · View at Google Scholar
  21. G. Chaudhri, V. Tahiliani, P. Eldi, and G. Karupiah, “Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses,” Journal of Virology, vol. 89, no. 3, pp. 1889–1899, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bray and M. E. Wright, “Progressive vaccinia,” Clinical Infectious Diseases, vol. 36, no. 6, pp. 766–774, 2003. View at Publisher · View at Google Scholar
  23. J. E. Stajich, D. Block, K. Boulez et al., “The Bioperl toolkit: perl modules for the life sciences,” Genome Research, vol. 12, no. 10, pp. 1611–1618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Vita, J. A. Overton, J. A. Greenbaum et al., “The immune epitope database (IEDB) 3.0,” Nucleic Acids Research, vol. 43, no. 1, pp. D405–D412, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. Reche, H. Zhang, J.-P. Glutting, and E. L. Reinherz, “EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology,” Bioinformatics, vol. 21, no. 9, pp. 2140–2141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. Bendtsen, H. Nielsen, G. von Heijne, and S. Brunak, “Improved prediction of signal peptides: SignalP 3.0,” Journal of Molecular Biology, vol. 340, no. 4, pp. 783–795, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Sonnhammer, G. von Heijne, and A. Krogh, “A hidden Markov model for predicting transmembrane helices in protein sequences,” in Proceedings of the International Conference on Intelligent Systems for Molecular Biology (ISMB '98), vol. 6, pp. 175–182, Montreal, Canada, June-July 1998.
  28. E. J. Lefkowitz, C. Upton, S. S. Changayil, C. Buck, P. Traktman, and R. M. L. Buller, “Poxvirus Bioinformatics Resource Center: a comprehensive Poxviridae informational and analytical resource,” Nucleic Acids Research, vol. 33, pp. D311–D316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. A. Reche, J.-P. Glutting, and E. L. Reinherz, “Prediction of MHC class I binding peptides using profile motifs,” Human Immunology, vol. 63, no. 9, pp. 701–709, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. Reche, J.-P. Glutting, H. Zhang, and E. L. Reinherz, “Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles,” Immunogenetics, vol. 56, no. 6, pp. 405–419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. P. A. Reche and E. L. Reinherz, “Prediction of peptide-MHC binding using profiles,” Methods in Molecular Biology, vol. 409, pp. 185–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. A. Reche and E. L. Reinherz, “Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms,” Journal of Molecular Biology, vol. 331, no. 3, pp. 623–641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. C. M. Diez-Rivero, E. M. Lafuente, and P. A. Reche, “Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome,” BMC Bioinformatics, vol. 11, article 479, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. Blum, P. A. Wearsch, and P. Cresswell, “Pathways of antigen processing,” Annual Review of Immunology, vol. 31, no. 1, pp. 443–473, 2013. View at Publisher · View at Google Scholar
  35. W. E. Demkowicz Jr., R. A. Littaua, J. Wang, and F. A. Ennis, “Human cytotoxic T-cell memory: long-lived responses to vaccinia virus,” Journal of Virology, vol. 70, no. 4, pp. 2627–2631, 1996. View at Google Scholar · View at Scopus
  36. B. Moss, “Smallpox vaccines: targets of protective immunity,” Immunological Reviews, vol. 239, no. 1, pp. 8–26, 2011. View at Publisher · View at Google Scholar
  37. M. Moutaftsi, S. Salek-Ardakani, M. Croft et al., “Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model,” European Journal of Immunology, vol. 39, no. 3, pp. 717–722, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Kastenmuller, I. Drexler, H. Ludwig et al., “Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity,” Virology, vol. 350, no. 2, pp. 276–288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. M. Diez-Rivero, M. Garcia-Boronat, and P. A. Reche, “Integrating T-cell epitope annotations with sequence and structural information using DAS,” Bioinformation, vol. 3, no. 4, pp. 156–158, 2008. View at Publisher · View at Google Scholar
  40. C. P. Toseland, D. J. Clayton, H. McSparron et al., “AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data,” Immunome Research, vol. 1, no. 1, article 4, 2005. View at Google Scholar
  41. C. Oseroff, F. Kos, H.-H. Bui et al., “HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13980–13985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. C. L. Smith, F. Mirza, V. Pasquetto et al., “Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara,” The Journal of Immunology, vol. 175, no. 12, pp. 8431–8437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Jing, D. H. Davies, T. M. Chong et al., “An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling,” Journal of Virology, vol. 82, no. 14, pp. 7120–7134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Meyer, G. Sutter, and A. Mayr, “Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence,” Journal of General Virology, vol. 72, no. 5, pp. 1031–1038, 1991. View at Publisher · View at Google Scholar · View at Scopus
  45. J. W. Golden and J. W. Hooper, “The strategic use of novel smallpox vaccines in the post-eradication world,” Expert Review of Vaccines, vol. 10, no. 7, pp. 1021–1035, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Kim, H. Yang, S.-K. Kim et al., “Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies,” The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25838–25848, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Yang, S.-K. Kim, M. Kim et al., “Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 379–387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. E. M. Lafuente and P. A. Reche, “Prediction of MHC-peptide binding: a systematic and comprehensive overview,” Current Pharmaceutical Design, vol. 15, no. 28, pp. 3209–3220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. P. A. Reche and E. L. Reinherz, “PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands,” Nucleic Acids Research, vol. 33, no. 2, pp. W138–W142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Sette and J. Sidney, “HLA supertypes and supermotifs: a functional perspective on HLA polymorphism,” Current Opinion in Immunology, vol. 10, no. 4, pp. 478–482, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Molero-Abraham, E. M. Lafuente, D. R. Flower, and P. A. Reche, “Selection of conserved epitopes from hepatitis c virus for pan-populational stimulation of T-cell responses,” Clinical and Developmental Immunology, vol. 2013, Article ID 601943, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Zhong, P. A. Reche, C.-C. Lai, B. Reinhold, and E. L. Reinherz, “Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire,” Journal of Biological Chemistry, vol. 278, no. 46, pp. 45135–45144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Kastenmuller, G. Gasteiger, J. H. Gronau et al., “Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination,” Journal of Experimental Medicine, vol. 204, no. 9, pp. 2187–2198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. C. M. Diez-Rivero and P. A. Reche, “CD8 T cell epitope distribution in viruses reveals patterns of protein biosynthesis,” PLoS ONE, vol. 7, no. 8, Article ID e43674, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. P. A. Reche and E. L. Reinherz, “Definition of MHC supertypes through clustering of MHC peptide-binding repertoires,” Methods in Molecular Biology, vol. 409, pp. 163–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. B. E. Pickett, E. L. Sadat, Y. Zhang et al., “ViPR: an open bioinformatics database and analysis resource for virology research,” Nucleic Acids Research, vol. 40, no. 1, pp. D593–D598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. C. M. Diez-Rivero, B. Chenlo, P. Zuluaga, and P. A. Reche, “Quantitative modeling of peptide binding to TAP using support vector machine,” Proteins: Structure, Function, and Bioinformatics, vol. 78, no. 1, pp. 63–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Saveanu, O. Carroll, V. Lindo et al., “Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum,” Nature Immunology, vol. 6, no. 7, pp. 689–697, 2005. View at Publisher · View at Google Scholar · View at Scopus